Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Ketamine edges out ECT for refractory depression in small study

Publish date:: June 29, 2019

Key clinical point: Although both electorconvulsive therapy and ketamine worked well for refractory depression, ketamine had the early edge.

Major finding: Improvements in HDRS scores were greater after both single and serial ketamine (P less than .001).

Study details: A nonrandomized study of nearly 100 patients treated with ketamine or electroconvulsive therapy.

Disclosures: The work was funded by the National Institutes of Health. Dr. Narr had no disclosures.

Citation:

Narr K et al., Presented at APA 2019.

This Week's Must Reads

MDD: Modest improvements in female sexual functioning with adjunctive brexpiprazole,

Transcranial direct current stimulation not clinically relevant in MDD,

Interleukin-1 β and TNF-α hamper antidepressant response in MDD,

Impact of pimavanserin on anxious depression in patients with MDD,

Prior MDD moderates the association between endothelin-1 and post-ACS depressive symptoms,

Must Reads in Depression

Rap music mention of mental health topics more than doubles,

Social factors predicted peripartum depressive symptoms in Black women with HIV,

Mental health risks rise with age and stage for gender-incongruent youth,

Teen affective disorders raise risk for midlife acute MI,

Divergent COVID-19 mental health impacts seen in Spain and China,

All Specialties